83 related articles for article (PubMed ID: 16614124)
1. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in predictors of colorectal cancer screening uptake: a national cross sectional study based on the health belief model.
Wong RK; Wong ML; Chan YH; Feng Z; Wai CT; Yeoh KG
BMC Public Health; 2013 Jul; 13():677. PubMed ID: 23879593
[TBL] [Abstract][Full Text] [Related]
3. Exploring Gender Disparities in Factors Influencing Colorectal Cancer Screening Compliance in Singapore.
Huang Q; Tan LY
Asian Pac J Cancer Prev; 2024 Mar; 25(3):867-873. PubMed ID: 38546069
[TBL] [Abstract][Full Text] [Related]
4. Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England.
Miles A; Rainbow S; von Wagner C
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2132-40. PubMed ID: 21953115
[TBL] [Abstract][Full Text] [Related]
5. Screening practices in cancer survivors.
Mayer DK; Terrin NC; Menon U; Kreps GL; McCance K; Parsons SK; Mooney KH
J Cancer Surviv; 2007 Mar; 1(1):17-26. PubMed ID: 18648941
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Related Information Seeking Among Cancer Survivors: Trends Over a Decade (2003-2013).
Finney Rutten LJ; Agunwamba AA; Wilson P; Chawla N; Vieux S; Blanch-Hartigan D; Arora NK; Blake K; Hesse BW
J Cancer Educ; 2016 Jun; 31(2):348-57. PubMed ID: 25712202
[TBL] [Abstract][Full Text] [Related]
7. Meeting the healthy people 2020 goals: using the Health Information National Trends Survey to monitor progress on health communication objectives.
Hesse BW; Gaysynsky A; Ottenbacher A; Moser RP; Blake KD; Chou WY; Vieux S; Beckjord E
J Health Commun; 2014 Dec; 19(12):1497-509. PubMed ID: 25491584
[TBL] [Abstract][Full Text] [Related]
8. Health information-seeking on behalf of others: characteristics of "surrogate seekers".
Cutrona SL; Mazor KM; Vieux SN; Luger TM; Volkman JE; Finney Rutten LJ
J Cancer Educ; 2015 Mar; 30(1):12-9. PubMed ID: 24989816
[TBL] [Abstract][Full Text] [Related]
9. Determinants of participation in colorectal cancer screening with faecal occult blood testing.
von Euler-Chelpin M; Brasso K; Lynge E
J Public Health (Oxf); 2010 Sep; 32(3):395-405. PubMed ID: 20015868
[TBL] [Abstract][Full Text] [Related]
10. Attitudes towards and beliefs about colorectal cancer and screening using the faecal occult blood test within the Italian-Australian community.
Severino G; Wilson C; Turnbull D; Duncan A; Gregory T
Asian Pac J Cancer Prev; 2009; 10(3):387-94. PubMed ID: 19640179
[TBL] [Abstract][Full Text] [Related]
11. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
[TBL] [Abstract][Full Text] [Related]
12. Fatalistic beliefs about cancer prevention and three prevention behaviors.
Niederdeppe J; Levy AG
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):998-1003. PubMed ID: 17507628
[TBL] [Abstract][Full Text] [Related]
13. Participation in colorectal cancer screening: a review.
Vernon SW
J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.
Herbert C; Launoy G; Gignoux M
Eur J Cancer Prev; 1997 Feb; 6(1):44-52. PubMed ID: 9161812
[TBL] [Abstract][Full Text] [Related]
15. Assessing the clinical utility of genetic risk scores for targeted cancer screening.
Conran CA; Shi Z; Resurreccion WK; Na R; Helfand BT; Genova E; Zheng SL; Brendler CB; Xu J
J Transl Med; 2021 Jan; 19(1):41. PubMed ID: 33482857
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in self-reported family history of cancer: A review and secondary data analysis.
Sieverding M; Arbogast AL; Zintel S; von Wagner C
Cancer Med; 2020 Oct; 9(20):7772-7780. PubMed ID: 32835456
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening.
Murphy CC; Halm EA; Skinner CS; Balasubramanian BA; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1557-1563. PubMed ID: 32457184
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
19. Cancer worry frequency vs. intensity and self-reported colorectal cancer screening uptake: A population-based study.
Vrinten C; Stoffel S; Dodd RH; Waller J; Lyratzopoulos Y; von Wagner C
J Med Screen; 2019 Dec; 26(4):169-178. PubMed ID: 31042098
[TBL] [Abstract][Full Text] [Related]
20. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
